Use of Rapid Drug Desensitization in Delayed Hypersensitivity Reactions to Chemotherapy and Monoclonal Antibodies

BACKGROUND: Rapid drug desensitization (RDD) allows first-line therapies in patients with immediate drug hypersensitivity reactions (DHR) to chemotherapeutic drugs (ChD) and monoclonal antibodies (mAb). Desensitization in delayed drug reactions has traditionally used slow protocols extending up to s...

Descripción completa

Detalles Bibliográficos
Autores principales: Vega, Arantza, Peña, M. Isabel, Torrado, Inés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Allergy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974726/
https://www.ncbi.nlm.nih.gov/pubmed/35387014
http://dx.doi.org/10.3389/falgy.2021.786863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974726/
https://www.ncbi.nlm.nih.gov/pubmed/35387014
http://dx.doi.org/10.3389/falgy.2021.786863

Ejemplares similares